The Cardiovascular Care Group, nationally recognized for vascular and endovascular care, has emerged as the region’s leader in endovascular thrombectomy (EVT) procedures. The group has been providing high-quality vascular care to patients for more than 60 years and has a proven track record of excellence and innovation.
Endovascular thrombectomy is a minimally-invasive procedure used to remove blood clots from an artery or vein. This allows the physician to remove a blood clot from the circulation without the need for surgery or an incision. This procedure is highly effective in treating patients with deep vein thrombosis, a type of blood clot in the legs and arms, or even if the blood clot has traveled to the lung causing a life-threatening pulmonary embolism.
The Cardiovascular Care Group has been at the forefront of endovascular procedures, utilizing the latest technology and techniques to provide superior patient care. Their team of highly skilled, board-certified vascular physicians, physician assistants, and support staff work together to ensure that each patient receives personalized care and treatment.
“EVT is the next step when traditional clot-buster medications do not or cannot work,” said NJ Top Doc Dr. Clifford Sales, managing partner at The Cardiovascular Care Group. “The procedure can be performed effectively, which is important when it comes to treating or preventing a pulmonary embolism. We simply pass a microwire through a pinhole to the area of their clot and then use a sophisticated device
to remove the blood clot. This is typically done using only local anesthesia and some sedation for comfort.
The Group has performed hundreds of endovascular thrombectomy procedures, and, along with their highly-skilled vascular doctors, has achieved superior success rates. The Cardiovascular Care Group has also been long recognized for their excellence in patient care and satisfaction, receiving numerous awards and accolades.
“We are dedicated to providing the latest medical technologies to our patients, and we are proud of the outcomes we have achieved,” said NJ Top Doc Dr. Scott Sundick, one of the vascular surgeons at the Cardiovascular Care Group. “EVT has recently received a lot of attention for its new application with acute ischemic stroke patients. However, we have been using this procedure for our vascular patients for years.”
Patients who undergo endovascular thrombectomy procedures at The Cardiovascular Care Group can expect to receive the highest level of compassion and expert treatment. The group is committed to providing its patients optimal health outcomes.
To learn more about The Cardiovascular Care Group and their endovascular thrombectomy procedures and the 15 board-certified vascular physicians who are trained in the latest techniques and procedures in vascular medicine, visit www.tcvcg.com.
About The Cardiovascular Care Group
The Cardiovascular Care Group is New Jersey’s largest and most experienced vascular surgery group dedicated solely to the diagnosis and management of diseases of the arteries and veins. Since their inception in 1963, the group has remained committed to providing quality care using the newest technologies to deliver the best outcomes for patients. The board-certified physicians are highly trained in all techniques for management of vascular disease, including carotid artery disease, aortic aneurysms, peripheral artery disease, varicose and spider veins, and dialysis creation and maintenance. For more information, visit www.tcvcg.com or call 973-759-9000.